Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Older Adults With Acute Lymphoblastic Leukemia

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Acute lymphoblastic leukemia, excluding known mature B-cell ALL by the presence of any of the following: surface immunoglobulin, L3 morphology, t(8;14)(q24;q32), t(8;22), or t(2;8).~* Patients with mature B-cell ALL will be removed from the protocol as soon as the diagnosis is made and should be treated on a B-cell leukemia protocol.~* Patients with lymphoblastic lymphoma are also eligible~* No prior anti-leukemic therapy except \<1 week of steroids, and/or emergent radiation therapy to the mediastinum, or hydroxyurea or emergent leukopheresis. Longer steroid use for diseases other than leukemia is permitted.~* Age 51-75 years~* Ejection fraction \> 45%~* Creatinine \< 2.0 mg/dl~* Total bilirubin \< 3.0 mg/dl~* ECOG (Eastern Cooperative Oncology Group) Performance Status of 0, 1, 2~* Non-pregnant and non lactating~Exclusion Criteria:~* Known HIV positive~* Comorbid medical condition, in the investigator's opinion, would make participation in this trial and adherence to the protocol guidelines difficult~* Active psychiatric or mental illness making informed consent or careful clinical follow-up unlikely

- Gender: ALL
- Minimum Age: 51 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Experimental (Type: EXPERIMENTAL): All patients treated on same arm

Based on this trial design, predict the completion outcome and termination type (if applicable).